key: cord-0690766-s44p88oo
authors: Kiani, P.; Merlo, A.; Saeed, H.M.; Severeijns, N.R.; Sips, A.S.M.; Bruce, G.; Kraneveld, A.D.; Garssen, J.; Verster, J.C.
title: P.0492 Impact of mood and stress during COVID-19 lockdown on perceived immune fitness and the presence and severity of COVID-19 symptoms
date: 2021-12-30
journal: Eur Neuropsychopharmacol
DOI: 10.1016/j.euroneuro.2021.10.464
sha: 150ae1f5af1251dc989cd2ae84226d0b821b7fe5
doc_id: 690766
cord_uid: s44p88oo

nan

Background: To address the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) around the world, in the absence of a vaccine or adequate treatment for the 2019 coronavirus disease (COVID-19), many governments around the world enforced lockdown periods. While lockdowns are beneficial in reducing the spread of the virus, literature shows that lockdowns may also have a significant negative impact on mood, wellbeing, and health. In this context, we hypothesized that negative mood changes increase overall stress levels, which in turn has a negative effect on perceived immune fitness, expressed in a greater presence and severity of COVID-19 symptoms [1] . Objective: The aim of this study was to investigate the impact of mood and stress during COVID-19 lockdown on perceived immune fitness and reported COVID-19 symptoms. Methods: An online retrospective survey was held among Dutch adults, to evaluate the first lockdown in The Nether-lands [1] . Questions were answered for the period before the lockdown (15 January-14 March 2020) as well as for the lockdown period (15 March-11 May 2020). Mood was assessed via 1-item scales including "stress", "anxiety", "depression", "fatigue", "hostile", "lonely" and "happy" [2] . Perceived immune fitness was assessed on a scale ranging from 0 (very poor) to 10 (excellent) [3] . The COVID-19 Symptoms Scale comprised the items sneezing, running nose, sore throat, cough, and malaise/feeling sick, high temperature (up to 38 Celsius), fever (38 Celsius and higher), shortness of breath, and chest pain [1] . The severity of each of the nine items could be rated as none (0), mild (1), moderate (2), or severe (3). The sum score of items served as COVID-19 symptom severity score, with a possible range from 0 (no complaints) to 27 (severe complaints). In addition, the presence of COVID-19 symptoms was calculated by counting the number of symptoms with a score > 0.

Assessments before and during COVID19 lockdown were compared using the Related Samples Wilcoxon Signed Rank Test. For each variable, difference scores ( , lockdownbefore lockdown) were calculated. Pearson's correlations were calculated between difference scores. Results: Data of 1415 Dutch adults (64% women, age range: 18 to 94 years old) were analyzed. During lockdown, all mood ratings, stress, and perceived immune fitness were significantly poorer compared to the period before lockdown (p < 0.0001). The COVID-19 symptom severity score as significantly higher during the lockdown period (p = 0.018), but no difference was found for the number of reported COVID-19 symptoms (p = 0.256). Significant correlations were found between mood changes and stress (r ranged from 0.334 to 0.557, all p < 0.0001). The correlation between stress and perceived immune fitness was also significant (r = -0.310, p < 0.0001). Finally, perceived immune fitness correlated significantly with difference scores for the presence (r = -0.223, p < 0.0001) and severity (r = -0.245, p < 0.0001) of COVID-19 related symptoms. Conclusions: The findings support the hypothesis that lockdown has a negative effect on mood and increases stress. This is reflected in poorer perceived immune fitness, which in turn is associated with a greater presence and severity of COVID-19 symptoms. Background: COVID-19 outbreak is a public emergency that forced people to a radical change in their daily life, generating great insecurities and concerns about health, work, and social relationships [1] . Quarantine measures were responsible for detrimental effects on mental health of the general population, leading to the exacerbation of stress, depression and anxiety [2] . Psychological impact might be even more severe on fragile people such as those suffering from rheumatic diseases (RDs), for whom previous evidence demonstrated a negative effect of psychological stressors on outcome disease [3] . Objective: The aim of the present study is to identify the factors associated with higher levels of perceived stress in patients affected by RDs during the COVID-19 pandemic. Methods: This cross-sectional study analyzed data from an anonymous online survey about mental health of people with RDs. Participants were enrolled through several RD patients' associations between May and September 2020, after the first pandemic wave in Italy. They filled out a questionnaire including demographic and clinical information, mental health issues and the Perceived Stress Scale (PSS). Perceived stress levels were stratified as follows: low ( < 14), moderate (14-26) and high ( > 27). Descriptive analyses were performed on the total sample; one-way analyses of variance (ANOVA) and Pearson's correlation were used to compare PSS scores between groups defined by qualitative and quantitative variables. Finally, multivariate regression analyses were performed to identify independent variables associated with higher PSS scores. Results: 507 patients with RDs participated in the survey: 419 females (82.6%) and 88 males (17.4%) with a mean age of 53.06 years and mean disease duration of 13.74 years. As regard PSS scores, total sample mean (SD) was 18.1 ± 8.1. Specifically, 154 patients (30,4%) reported low, 264 (52.1%) moderate and 89 (17.6%) high levels of stress. PSS scores resulted significantly different with regard to: gender (F = 18.32, P < 0.01), residence in Lombardy (F = 14.90, P < 0.01), diagnostic group (F = 6.20, P < 0.01), hypertension (F = 4.06, P = 0.04), gastritis (F = 3.83, P = 0.05), bowel diseases (F = 9.74, P < 0.01), overweight/obesity (F = 5.96, P = 0.02), COVID-19 infection (F = 4.32, P = 0.01), depressive symptoms (F = 17.18, P < 0.01), anxiety symptoms (F = 19.79, P < 0.01), prescription of psychiatric therapy before COVID-19 (F = 30.90, P < 0.01), type of pre-existing psychiatric symptoms (F = 12.41, P < 0.01), use of psychiatric compounds before COVID-19 (F = 36.39, P < 0.01), type of psychiatric compounds before COVID-19 (F = 13.53, P < 0.01), current

Ultra-fast magnetic resonance encephalography of physiological brain activity -Glymphatic pulsation mechanisms

Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep

Cardiovascular brain impulses in Alzheimer's disease

Sleep Drives Metabolite Clearance from the Adult Brain

Increased glymphatic influx is correlated with high EEG delta power and low heart rate in mice under anesthesia

Immune fitness, and the psychosocial and health consequences of the COVID-19 pandemic lockdown in The Netherlands: methodology and design of the CLOFIT study

The use of single-item ratings versus traditional multiple-item questionnaires to assess mood and health

Development and validation of the Immune Status Questionnaire (ISQ)